Literature DB >> 22277026

Photodynamic therapy in a teenage girl with xeroderma pigmentosum type C.

David M Larson1, Bari B Cunningham.   

Abstract

Despite aggressive sun protection, most individuals with xeroderma pigmentosum (XP) develop cutaneous neoplasia, including actinic keratoses. We describe the case of a 16-year-old girl with XP type C treated safely with photodynamic therapy (PDT). Although there is little if any evidence in the literature supporting the use of aminolevulinic acid PDT in individuals with XP, they may be the ideal candidates for PDT treatment because the profound post-treatment photosensitivity and strict post-therapy sun avoidance necessitated by PDT treatment is already part of the everyday lifestyle of people with XP.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277026     DOI: 10.1111/j.1525-1470.2011.01657.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

Review 1.  Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.

Authors:  Fernando Antônio Gomes de Andrade; Claudio Eduardo de Oliveira Cavalcanti; Felipe Contoli Isoldi; Lydia Masako Ferreira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

Review 2.  Current Therapeutic Strategies of Xeroderma Pigmentosum.

Authors:  Mozammel Hossain; Ashraful Hasan; Mohammad Mahfuz Ali Khan Shawan; Subrata Banik; Iffat Jahan
Journal:  Indian J Dermatol       Date:  2021 Nov-Dec       Impact factor: 1.494

Review 3.  Photodynamic therapy in pediatric age: Current applications and future trends.

Authors:  Luca Di Bartolomeo; Domenica Altavilla; Mario Vaccaro; Federico Vaccaro; Violetta Squadrito; Francesco Squadrito; Francesco Borgia
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

4.  Effects of photodynamic therapy on dermal fibroblasts from xeroderma pigmentosum and Gorlin-Goltz syndrome patients.

Authors:  Alicia Zamarrón; Marta García; Marcela Del Río; Fernando Larcher; Ángeles Juarranz
Journal:  Oncotarget       Date:  2017-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.